We are very excited to announce that Kim Kerin-Ayres will be joining TSA as our new telehealth nurse.
GW Pharmaceuticals has announced positive top-line results of a Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Tuberous Sclerosis Complex (TSC). This is exciting news and a step further along the … Read More
The Elizabeth Pinkerton Memorial Award is presented annually by Tuberous Sclerosis Australia to a health professional to recognise their efforts in improving the lives of TSC-affected people and their families in Australia. TSA is now pleased to seek nominations for … Read More
You are invited to join TSA at our very first Connect event for adults living with TSC. The event will include TSC expert speakers, a chance to meet and connect with others living with TSC and an opportunity to discuss what further support … Read More
The April 2019 edition of Reach Out is now available to read online. This issue’s contents include: Stories from TSC families about their experiences with a new diagnosis of TSC Welcoming TSA’s new General Manager Invitation to join TSA at … Read More
The Elizabeth Pinkerton Memorial award is given annually by Tuberous Sclerosis Australia to a health professional to recognise their efforts to improve the lives of TSC affected people and their families in Australia. Elizabeth (Lizzie) Pinkerton (1984 – 2010) had … Read More
It was announced today that TSA is one of 11 patient organisations that will receive funding support for a part-time telehealth nurse under the Patient Pathways program developed by the Centre for Community-Driven Research (CCDR). This pilot project is intended … Read More